Vietnam is approaching a demographic transformation that could significantly reshape its healthcare industry.
According to the United Nations Population Fund (UNFPA), people aged 60 and older accounted for approximately 11.9% of Vietnam’s population in 2019.
By 2050, that proportion is projected to exceed 25%.
In other words, more than one in four Vietnamese could be aged 60 or older.
This is not simply a story about people living longer.
It is a structural change that will influence how healthcare services are delivered, how medical infrastructure is developed and where long-term investment opportunities emerge.
One sector deserves particular attention.
Diagnostic laboratories.
As populations age, demand for chronic disease monitoring, cancer diagnosis and specialised medical investigations can increase.
These services depend on clinical laboratories, pathology departments and increasingly sophisticated testing technologies.
For Vietnam, the important question is not simply whether the country will need more diagnostic tests.
It is whether existing laboratory infrastructure can support a larger population of older patients requiring more complex and continuous healthcare.
That challenge could create opportunities for laboratory operators, specialist pathology providers and investors developing integrated diagnostic networks.
Vietnam Is Ageing Faster Than Many Developed Countries
Vietnam’s demographic transition is occurring at a remarkable pace.
The country has experienced substantial improvements in life expectancy alongside declining fertility rates.
As people live longer and fewer children are born, older adults represent a growing share of the population.
UNFPA projects that Vietnam will transition from an ageing society to an aged society around 2036.
In February 2026, the organisation reported that more than one in five Vietnamese citizens could be aged over 60 within approximately a decade.
By 2050, that proportion is expected to exceed one-quarter of the population.
Earlier official projections have suggested that Vietnam could have approximately 27 million people aged 60 or older by 2050.
Although population estimates vary depending on demographic assumptions, their direction is consistent.
Vietnam is moving toward a significantly older population.
This transition will affect retirement systems, social services and household spending.
However, healthcare may experience some of the most direct consequences.
Older populations typically require different patterns of medical care than younger populations.
The emphasis increasingly shifts from treating isolated episodes of illness toward managing chronic conditions, preventing complications and maintaining health over longer periods.
This shift could make diagnostic testing an increasingly important component of Vietnam’s healthcare infrastructure.
Why Population Ageing Creates Demand for Diagnostic Services
Ageing does not automatically mean illness.
Many older adults remain healthy and active.
However, the probability of developing certain medical conditions generally increases with age.
These include diabetes, cardiovascular disease, chronic kidney disease, cancer and several neurological disorders.
Many older patients also live with more than one chronic condition.
This creates a different relationship between patients and healthcare providers.
A younger patient may undergo laboratory testing occasionally.
A patient managing diabetes or chronic kidney disease may require regular investigations to monitor disease progression and evaluate treatment.
A cancer patient may need multiple stages of diagnosis, treatment assessment and follow-up.
The result is potentially more frequent interaction with diagnostic services over an extended period.
For laboratories, the economic implications are important.
Healthcare demand can shift from one-time diagnostic episodes toward recurring, medically indicated testing.
Instead of relying exclusively on new patient encounters, laboratory operators may develop long-term relationships with healthcare institutions providing continuous disease management.
However, testing frequency must remain determined by clinical guidelines and individual patient needs.
Population ageing is a driver of potential demand, not a justification for unnecessary medical investigations.
Chronic Diseases Already Account for Most Deaths in Vietnam
The growing importance of diagnostics is not merely a future possibility.
Vietnam already faces a substantial burden of chronic noncommunicable diseases.
According to the World Health Organization, noncommunicable diseases account for approximately 80% of deaths in Vietnam.
These diseases include cardiovascular conditions, cancer, chronic respiratory diseases and diabetes.
In December 2025, WHO and Vietnam’s Ministry of Health emphasised the need to strengthen prevention, early detection and long-term management of these conditions.
Laboratory testing is essential to many of these activities.
For example, diabetes management commonly involves blood glucose and HbA1c testing.
Kidney disease monitoring uses investigations such as serum creatinine, estimated glomerular filtration rate and urine albumin measurements.
Cardiovascular risk assessment can involve lipid testing and investigations related to associated metabolic conditions.
As the number of patients receiving long-term medical management increases, healthcare providers may require greater access to reliable routine laboratory services.
This could strengthen demand for clinical chemistry, haematology, immunology and other diagnostic disciplines.
It could also increase the importance of laboratory information systems that support accurate reporting and longitudinal patient monitoring.
Cancer Diagnostics Could Become Increasingly Important
Cancer represents another important connection between population ageing and laboratory demand.
The incidence of many cancers rises with age.
Vietnam already has a substantial cancer burden.
According to the International Agency for Research on Cancer’s GLOBOCAN 2022 estimates, the country recorded approximately 180,480 new cancer cases in 2022.
Common cancers included breast, liver, lung, colorectal and stomach cancer.
Ageing is only one factor influencing cancer incidence.
Other factors include lifestyle, environmental exposure, infections, inherited risks and screening practices.
Nevertheless, an older population could increase the absolute number of patients requiring cancer-related healthcare, even if age-specific incidence rates remained unchanged.
Cancer diagnosis frequently depends on specialised laboratory services.
A suspicious lesion may require a biopsy.
The tissue specimen must then be processed, examined and interpreted by a qualified pathologist.
Additional testing may be necessary to determine tumour characteristics and guide treatment.
These investigations can include immunohistochemistry and selected molecular diagnostic tests.
As cancer care becomes more personalised, the need for accurate tissue diagnosis and biomarker testing may also increase.
For laboratory operators, this creates opportunities beyond routine blood testing.
Histopathology and specialised cancer diagnostics could become increasingly important parts of Vietnam’s diagnostic services market.
Why Histopathology Is Different From Routine Laboratory Testing
Routine clinical laboratory services can often expand capacity through automation, equipment investment and improvements in workflow.
Histopathology presents a different challenge.
Although equipment is essential, the diagnostic process depends heavily on specialised medical expertise.
Pathologists examine tissue specimens to determine whether disease is present and, when appropriate, classify its characteristics.
Complex cases may require advanced staining, additional investigations and specialist consultation.
Developing these capabilities takes time.
A laboratory can purchase a tissue processor, staining instruments or digital scanner relatively quickly.
It cannot develop an experienced pathologist simply by purchasing equipment.
Medical training, clinical experience and specialised knowledge remain essential.
This creates a potential barrier to entry.
An established histopathology laboratory with qualified specialists, appropriate quality systems and strong clinical relationships may possess capabilities that are difficult for new competitors to reproduce.
For investors evaluating Vietnam’s diagnostic market, this distinction matters.
The strategic value of a laboratory should not be assessed solely through its equipment, floor area or testing volume.
Its medical workforce and diagnostic expertise may be equally important.
An Older Population May Need More Specialised Diagnostic Networks
The future demand for diagnostics also raises questions about how laboratories should be organised.
One approach is for each hospital or independent laboratory to develop its own comprehensive testing capabilities.
This model may be appropriate for high-volume routine testing and investigations requiring rapid results.
However, it may be inefficient for certain specialised services.
Advanced histopathology, molecular diagnostics and complex immunological testing often require expensive equipment, specialised personnel and ongoing quality management.
Individual laboratories may not always generate sufficient testing volume to justify maintaining these capabilities independently.
A laboratory network offers an alternative.
Local laboratories can continue performing routine investigations and managing specimen collection.
Specialised reference laboratories can process selected complex tests for multiple healthcare providers.
This model may improve equipment utilisation while expanding access to advanced diagnostics.
It can also support coordinated procurement, quality assurance and laboratory information systems.
However, centralisation must be selective.
Urgent tests, unstable specimens and investigations requiring immediate clinical decisions may need to remain close to patients.
The goal is not to centralise every laboratory activity.
It is to organise diagnostic capabilities according to clinical requirements and operational efficiency.
Digital Pathology Could Help Expand Access to Specialist Expertise
Technology may also influence how Vietnam responds to growing diagnostic demand.
Digital pathology allows tissue slides to be converted into high-resolution images for review on appropriate computer systems.
With validated workflows, qualified pathologists can potentially review cases remotely and collaborate with specialists at other locations.
This capability may be particularly relevant when experienced pathology professionals are concentrated in major medical centres.
For example, a provincial laboratory could prepare tissue specimens locally while requesting specialist consultation from a reference centre.
Digital pathology could reduce some of the delays associated with transporting physical slides for second opinions.
It may also support training, case conferences and subspecialty consultation.
However, implementation requires investment in scanning equipment, reliable information systems, secure data handling and quality assurance.
Digital pathology does not eliminate the need for qualified medical professionals.
Its potential value lies in making existing expertise more accessible.
A connected pathology network may allow specialist knowledge to support more laboratories without requiring every facility to employ every subspecialist.
What Does This Mean for Diagnostic Laboratory Investment?
Vietnam’s ageing population creates a long-term structural consideration for healthcare investors.
Unlike short-term changes in consumer demand, demographic transitions unfold over decades.
This can make ageing an important factor when evaluating healthcare infrastructure.
For diagnostic laboratories, several potential investment opportunities emerge.
The first is expanding routine testing capacity to support chronic disease management.
The second is developing specialised services such as histopathology, immunohistochemistry and molecular diagnostics.
The third is investing in technologies that improve laboratory efficiency, information management and specialist collaboration.
A fourth opportunity involves laboratory partnerships, acquisitions and consolidation.
Rather than developing every capability independently, established laboratory businesses may benefit from participation in larger networks.
These networks can potentially combine local healthcare relationships with shared specialist resources and selected centralised infrastructure.
However, demographic growth alone does not guarantee investment returns.
Laboratory operators must consider reimbursement policies, pricing, operating margins, workforce availability and the capital required for expansion.
Medical quality and regulatory compliance remain essential.
The investment thesis becomes stronger when demographic demand is supported by sustainable commercial operations and demonstrable clinical value.
Could Laboratory Consolidation Become More Important in Vietnam?
International diagnostic companies provide examples of how laboratory networks can operate at scale.
Large organisations such as Labcorp and Quest Diagnostics combine laboratory facilities, specimen logistics, technical infrastructure and clinical relationships across broad operating networks.
Their models demonstrate that diagnostic services can benefit from coordination between local healthcare providers and specialised testing centres.
Vietnam operates under different healthcare financing, regulatory and market conditions.
Nevertheless, some of the underlying economic considerations are similar.
Smaller laboratories may have established relationships with hospitals and physicians but lack the resources to develop advanced diagnostic services.
Specialised laboratories may possess valuable medical expertise but have limited geographic reach.
A larger network could potentially connect these complementary capabilities.
Acquisitions and partnerships may therefore become part of the industry’s development as laboratory operators seek greater efficiency and broader service offerings.
The key is preserving diagnostic quality and existing clinical relationships while developing shared capabilities.
Successful consolidation requires more than purchasing laboratories.
It requires clinical governance, operational integration and sustained investment in people and technology.
AsiaLabs and the Opportunity to Develop Vietnam’s Diagnostic Infrastructure
Vietnam’s demographic transformation provides an important long-term context for AsiaLabs’ investment strategy.
AsiaLabs focuses on developing and investing in laboratory businesses, including Anapath and Nguyễn Hoàng, while exploring opportunities for partnerships and expansion across Vietnam.
The strategic objective is to develop complementary laboratory capabilities within a broader diagnostic platform.
As demand for chronic disease monitoring and specialised pathology services grows, a connected laboratory network could offer advantages over isolated operations.
Participating laboratories may be able to combine established local clinical relationships with access to specialist expertise and selected shared resources.
For histopathology in particular, this approach could support the development of specialised diagnostic capabilities that are difficult for smaller laboratories to reproduce independently.
The value of such a platform would depend on its ability to improve clinical services, maintain quality and generate sustainable operating performance.
It would also require continuing investment in medical professionals, laboratory technology and systems that support cooperation between facilities.
For AsiaLabs, the broader opportunity is to participate in the development of Vietnam’s diagnostic infrastructure as the country’s healthcare needs evolve.
Conclusion: Demographic Change Could Reshape Vietnam’s Laboratory Industry
By 2050, more than one in four Vietnamese could be aged 60 or older.
This demographic shift will influence healthcare demand for decades.
Chronic disease monitoring, cancer diagnosis and specialised medical investigations could become increasingly important as the population ages.
For Vietnam’s diagnostic laboratory industry, the implications go beyond performing more tests.
The country may need more advanced diagnostic capabilities, better access to specialist pathologists and more effective coordination between local laboratories and reference centres.
For investors, this creates an opportunity to consider laboratory infrastructure from a long-term perspective.
The most valuable businesses may not simply be those with the largest testing volumes.
They may be those that combine reliable operations, established clinical relationships and access to specialised diagnostic expertise.
Vietnam’s population is ageing. Its diagnostic infrastructure will need to evolve with it.
The opportunity may not be limited to building more laboratories.
It may lie in developing the connected networks that allow those laboratories to serve an older population more effectively.